According to Vitrolife AB's latest financial reports the company has S$0.12 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | S$0.11 B | 51.53% |
2022-12-31 | S$74.51 M | -20.85% |
2021-12-31 | S$94.14 M | -40.14% |
2020-12-31 | S$0.15 B | 58.1% |
2019-12-31 | S$99.48 M | 33.23% |
2018-12-31 | S$74.66 M | 15.33% |
2017-12-31 | S$64.74 M | 114.68% |
2016-12-31 | S$30.15 M | -10.16% |
2015-12-31 | S$33.57 M | 83.05% |
2014-12-31 | S$18.33 M | 72.59% |
2013-12-31 | S$10.62 M | 383.67% |
2012-12-31 | S$2.19 M | -44.11% |
2011-12-31 | S$3.93 M | 10.61% |
2010-12-31 | S$3.55 M | 12.08% |
2009-12-31 | S$3.17 M | 23.93% |
2008-12-31 | S$2.55 M | -37.94% |
2007-12-31 | S$4.12 M | 613068.93% |
2006-12-31 | S$0 M | -99.99% |
2005-12-31 | S$10.1 M | -8.47% |
2004-12-31 | S$11.03 M | -9.26% |
2003-12-31 | S$12.16 M |